A substituted pyrimidine as a prostaglandin D2 receptor antagonist

Details for Australian Patent Application No. 2011227420 (hide)

Owner Aventis Pharmaceuticals Inc.

Inventors Harris, Keith John; Aguiar, Joacy C.; Shum, Patrick Wai-Kwok; Zhao, Zhicheng; Poli, Gregory B.; Stoklosa, Gregory T.; Choi-Sledeski, Yong-Mi; Reiling, Stephan

Agent Watermark

Pub. Number AU-A-2011227420

PCT Pub. Number WO2011/115943

Priority 61/314,421 16.03.10 US

Filing date 15 March 2011

Wipo publication date 22 September 2011

International Classifications

C07D 403/04 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/505 - Pyrimidines

A61P 11/00 Drugs for disorders of the respiratory system

Event Publications

4 October 2012 PCT application entered the National Phase

  PCT publication WO2011/115943 Priority application(s): WO2011/115943

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011227422-Set-top-box with integrated encoder/decoder for audience measurement

2011227418-Section mill and method for abandoning a wellbore